4'-甲氧基-3'-甲基乙酰苯胺 | 31910-25-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4'-甲氧基-3'-甲基乙酰苯胺
• 英文名称: N-(4-methoxy-3-methylphenyl)acetamide
• 英文别名: 4'-methoxy-3'-methylacetanilide；4-methoxy-3-methylacetanilide；acetic acid-(4-methoxy-3-methyl-anilide)；Essigsaeure-(4-methoxy-3-methyl-anilid)；4-Acetamino-o-kresol-methylaether；5-Acetamino-2-methoxy-toluol
• CAS: 31910-25-5
• 化学式: C₁₀H₁₃NO₂
• mdl: MFCD00128802
• 分子量: 179.219
• InChiKey: MPBJOBHAURZVBO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4'-甲氧基-3'-甲基乙酰苯胺 生成 2-氯-4-甲氧基-5-甲基-苯胺
  参考文献：
  名称：

  New ortho-aniline-sulfonic acid

  摘要：

  公开号：

  US01917441A1
• 作为产物：
  描述：

  2-甲基-4-硝基苯甲醚 在 乙醇 、 镍 作用下， 95.0~100.0 ℃ 、13.73 MPa 条件下， 生成 4'-甲氧基-3'-甲基乙酰苯胺
  参考文献：
  名称：

  5-甲基-6-甲氧基-8-（2'-二乙基氨基乙基氨基）-喹啉。

  摘要：

  DOI：

  10.1021/ja01212a048

文献信息

• Selective, Catalytic, and Metal-Free Coupling of Electron-Rich Phenols and Anilides Using Molecular Oxygen as Terminal Oxidant
  作者：Luis Bering、Melina Vogt、Felix M. Paulussen、Andrey P. Antonchick

  DOI：10.1021/acs.orglett.8b01631

  日期：2018.7.6

  Selective oxidative homo- and cross-coupling of electron-rich phenols and anilides was developed using nitrosonium tetrafluoroborate as a catalyst. Oxidative coupling of phenols revealed unusual selectivities, which translated into the unprecedented synthesis of inverse Pummerer-type ketones. Mechanistic studies suggest that oxidative coupling of phenols and anilides shares a common pathway via homolytical

  使用四氟硼酸氮鎓作为催化剂，开发了富电子的苯酚和苯甲酸酯的选择性氧化均相和交叉偶联。酚类的氧化偶联显示出不同寻常的选择性，这转化为反Pummerer型酮的空前合成。机理研究表明，酚和苯甲酸酯的氧化偶合通过均质杂原子-氢键裂解具有共同的途径。硝盐催化被应用到由杂原子为中心的自由基的产生引发的交叉脱氢偶联。
• PYRIMIDINE DERIVATIVES
  申请人：Kettle Jason Grant

  公开号：US20110046108A1

  公开（公告）日：2011-02-24

  The invention concerns benzamide compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R 1 , ring A, n, R 3 , and R 4 are as defined in the description. The present invention also relates to processes for the preparation of such compounds, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours or other proliferative conditions which are sensitive to the inhibition of EphB4, and/or EphA2 and/or Src kinases.

  这项发明涉及Formula (I)的苯甲酰胺化合物或其药用可接受的盐，其中R1、环A、n、R3和R4如描述中所定义。本发明还涉及制备这种化合物的方法、含有它们的药物组合物以及它们在制造用作抗增殖剂的药物中的用途，用于预防或治疗对EphB4、EphA2和/或Src激酶抑制敏感的肿瘤或其他增殖病症。
• Direct acetoxylation and etherification of anilides using phenyliodine bis(trifluoroacetate)
  作者：Huan Liu、Xuemin Wang、Yonghong Gu

  DOI：10.1039/c0ob00749h

  日期：——

  Treatment of various anilides with 1.5 equiv. of phenyliodine bis(trifluoroacetate) (PIFA) and 1.0 equiv. of BF3·OEt2 in AcOH at room temperature afforded the corresponding para-acetoxylated products with high regioselectivity. In addition, this reaction could be expanded to the etherification of anilides. In the presence of 2.0 equiv. of PIFA and 2.0 equiv. of BF3·OEt2, the reaction of anilides with alcohols provided the corresponding para-etherified products in good yields.

  用1.5当量的苯碘双(trifluoroacetate)（PIFA）和1.0当量的BF3·OEt2在醋酸中室温处理各种酰胺，得到了相应的对位乙氧基化产物，且具有高区位选择性。此外，该反应可以扩展到酰胺的醚化反应。在使用2.0当量的PIFA和2.0当量的 ·OEt2的条件下，酰胺与醇的反应提供了良产率的相应对位醚化产物。
• A novel CAN-SiO2-mediated one-pot oxidation of 1-keto-1,2,3,4-tetrahydrocarbazoles to carbazoloquinones: Efficient syntheses of murrayaquinone A and koeniginequinone A
  作者：Suchandra Chakraborty、Gautam Chattopadhyay、Chandan Saha

  DOI：10.1002/jhet.561

  日期：2011.3

  1‐keto‐1,2,3,4‐tetrahydrocarbazoles (1) to carbazole‐1,4‐quinones (2) are efficiently carried out by CAN‐SiO2‐mediated reaction. This generalized protocol was successfully extended to the synthesis of two naturally occurring carbazoloquinones: murrayaquinone A (2b) and koeniginequinone A (2g). A plausible mechanism for this novel reaction involves formation of a 9‐hydroxy‐2,3,4,9‐tetrahydro‐1H‐carbazole‐1‐one

  通过CAN-SiO 2介导的反应可以有效地将取代的1-酮-1,2,3,4-四氢咔唑（1）一锅法氧化为咔唑-1,4-醌（2）。该通用方案已成功扩展到两种天然存在的咔唑醌的合成：murrayaquinone A（2b）和koeniginequinone A（2g）。这种新反应的可能机制涉及形成9-羟基-2,3,4,9-四氢-1 H-咔唑-1-酮，然后重排为1-羟基咔唑衍生物，这些衍生物会被铈进一步氧化（IV ）到咔唑醌。J.杂环化​​学。（2011）。
• Quinolone sulphonates having antihypertensive activity
  申请人：The Boots Company, PLC

  公开号：US04997840A1

  公开（公告）日：1991-03-05

  Quinolone sulphonates of formula I ##STR1## in which R.sub.1 is lower alkyl; R.sub.2 is lower alkyl; and R.sub.3, R.sub.4 and R.sub.5, which may be the same or different, are hydrogen, lower alkyl, lower alkoxy, lower alkylthio, lower alkylsulphinyl, lower alkylsulphonyl, halo, halogenated lower alkyl, halogenated lower alkoxy, cyano, phenyl or phenyl substituted by 1 or 2 groups independently selected from lower alkyl, lower alkoxy and halo, have antihypertensive activity. Processes for preparing compounds of formula I and pharmaceutical compositions containing them are described. Compounds of formula I are also indicated for use in the treatment of heart failure and ischaemic heart disease.

  化学式I的喹诺酮磺酸盐：##STR1## 其中，R.sub.1为低碳基；R.sub.2为低碳基；R.sub.3、R.sub.4和R.sub.5可以相同也可以不同，分别为氢、低碳基、低氧基、低硫基、低硫氧基、低硫酰基、卤素、卤素化的低碳基、卤素化的低氧基、氰基、苯基或由1或2个从低碳基、低氧基和卤素中独立选择的基取代的苯基。这些化合物具有降压作用。本文还描述了制备化学式I化合物和含有它们的药物组合物的方法。化学式I的化合物也适用于治疗心力衰竭和缺血性心脏病。